China Hutchmed (00013) announced today that Hutchmed (China) Limited will hold a conference to share the latest research and development progress on July 9, 2024.
According to the announcement by Hutchmed (00013), Hutchmed (China) Limited will hold a conference in Shanghai, China on July 9th, 2024 (Tuesday) to share the latest research and development progress. The conference will be broadcast live online.
The senior management team will share the company's research and development strategy and vision at the conference. In addition, the management team will also share the latest progress of some projects in Hutchmed's rich and innovative candidate drug pipeline, including the ESLIM-01 Phase III study of Syk inhibitor Sovleplenib for the treatment of immune thrombocytopenia, the ESLIM-02 II/III phase study for the treatment of cold-reactive autoantibody type autoimmune hemolytic anemia, the II/III phase study of Surufatinib for the treatment of pancreatic duct glandular carcinoma, and the RAPHAEL III phase study of IDH1/IDH2 inhibitor HMPL-306 for the treatment of acute myeloid leukemia.
The offline conference will be held in Shanghai from 3pm to 5pm Hong Kong time, and the conference language will be in Chinese (Mandarin), and will be broadcast live online. The onsite event is only open to invited guests.
In addition, the English-language online conference will be held on July 9th (Tuesday) at 8:30pm Hong Kong time / 8:30am US Eastern Daylight Time / 1:30pm UK Summer Time, and will last for about 2 hours. The event will also be broadcast live online, and investors interested in listening to the online live broadcast can visit the website before the conference starts to download the required software. The conference replay can also be listened to within 90 days after the event.
Both conferences will be broadcast live online, and you can visit [the website] to listen. Investors interested in listening to the online live broadcast can visit the website before the conference starts to download the required software. The conference replay can also be listened to within 90 days after the event.